Skip to content
Recall Observatory FDA recall evidence

Exact FDA event identifier

Event 86584

6 recalled-product records grouped only because every row carries this exact official event ID.

Open FDA event record

Event summary

Timeline bucket
October 09, 2020
Product types
Drug
Classifications
Class III
Statuses
Terminated
Recalling firm wording
ANI Pharmaceuticals, Inc.

Dossier provenance

Source snapshots represented here

  • openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Complete imported group

Every recalled product in this event

6 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 5 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-277-10

D-0043-2021
Recall number
D-0043-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
408 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19S07 Exp. Sept. 2021

Distribution pattern

Distributed Nationwide in the USA

drug · product 2 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 10 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-278-10

D-0044-2021
Recall number
D-0044-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
13536 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19S10 Exp. Sept. 2021, 19S11 Exp. Oct. 2021

Distribution pattern

Distributed Nationwide in the USA

drug · product 3 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 15 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-279-10

D-0045-2021
Recall number
D-0045-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
13248 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19T14 Exp. Dec. 2021, 20D06 Exp. Apr. 2022

Distribution pattern

Distributed Nationwide in the USA

drug · product 4 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 20 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-280-10

D-0046-2021
Recall number
D-0046-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
24972 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19T15 Exp. Dec. 2021, 20D02, 20D03 Exp. Mar. 2022

Distribution pattern

Distributed Nationwide in the USA

drug · product 5 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 25 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-281-10

D-0047-2021
Recall number
D-0047-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
6780 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19T16 Exp. Jan. 2022

Distribution pattern

Distributed Nationwide in the USA

drug · product 6 of 6

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 30 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-282-10

D-0048-2021
Recall number
D-0048-2021
Initiated
October 09, 2020
Classification
Class III
Status
Terminated
Recalling firm
ANI Pharmaceuticals, Inc.
Quantity
34968 bottles

App-derived interpretation

Labeling or packaging reason.labeling_packaging · v1.0.0
Labeling: Incorrect

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Code information

Lot: 19T17 Exp. Dec. 2021, 19T18, 19T19, Exp. Jan. 2022; 20D05 Exp. Apr. 2022; 20D21, Exp. May 2022

Distribution pattern

Distributed Nationwide in the USA